Giovannoni, G., Soelberg Sorensen, P., Cook, S., Rammohan, K. W., Rieckmann, P., Comi, G., . . . Vermersch, P. (2019). Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study. Multiple sclerosis, 25(6), 819. https://doi.org/10.1177/1352458518771875
Citácia podle Chicago (17th ed.)Giovannoni, Gavin, Per Soelberg Sorensen, Stuart Cook, Kottil W. Rammohan, Peter Rieckmann, Giancarlo Comi, Fernando Dangond, Christine Hicking, a Patrick Vermersch. "Efficacy of Cladribine Tablets in High Disease Activity Subgroups of Patients with Relapsing Multiple Sclerosis: A Post Hoc Analysis of the CLARITY Study." Multiple Sclerosis 25, no. 6 (2019): 819. https://doi.org/10.1177/1352458518771875.
Citácia podľa MLA (8th ed.)Giovannoni, Gavin, et al. "Efficacy of Cladribine Tablets in High Disease Activity Subgroups of Patients with Relapsing Multiple Sclerosis: A Post Hoc Analysis of the CLARITY Study." Multiple Sclerosis, vol. 25, no. 6, 2019, p. 819, https://doi.org/10.1177/1352458518771875.